Weaver Capital Management
CELU icon

Weaver Capital Management’s Celularity CELU Stock Holding History

Weaver Capital Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-300
Closed -$399 – 185
2026
Q2 		$399 Hold
300
– – ﹤0.01% 171
2026
Q1 		$399 Hold
300
– – ﹤0.01% 173
2025
Q4 		$333 Hold
300
– – ﹤0.01% 183
2025
Q3 		$621 Hold
300
– – ﹤0.01% 190
2025
Q2 		$588 Hold
300
– – ﹤0.01% 187
2025
Q1 		$519 Hold
300
– – ﹤0.01% 183
2024
Q4 		$624 Hold
300
– – ﹤0.01% 184
2024
Q3 		$891 Hold
300
– – ﹤0.01% 171
2024
Q2 		$939 Hold
300
– – ﹤0.01% 167
2024
Q1 		$1.57K Buy
+300
New +$1.23K ﹤0.01% 161

Other funds holding CELU

C.V. Starr & Co
C.V. Starr & Co New York $187M AUM 12.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Biltmore Family Office
Biltmore Family Office Charlotte, North Carolina $752M AUM 22.25% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
Sky Investment Group
Sky Investment Group Hartford, Connecticut $931M AUM 17.48% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $704M AUM 30.39% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Caldwell Sutter Capital
Caldwell Sutter Capital Sausalito, California $268M AUM 23.48% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Weaver Capital Management's CELU Position: Q3 2026 in Review

Weaver Capital Management sold out of Celularity (CELU) in Q3 2026, closing a stake of 300 shares — an estimated $399 sold.

Weaver Capital Management first reported a position in CELU in Q1 2024 and held it in 10 quarters. The position peaked at $1.57K in Q1 2024. 17 funds tracked by Wall St. Rank hold CELU as of Q3 2026.

  • Weaver Capital Management reported no remaining Celularity position as of Q3 2026 after selling out during the quarter.
  • Weaver Capital Management sold 300 Celularity shares in Q3 2026, an estimated $399.
  • Weaver Capital Management first reported a position in Celularity in Q1 2024 and held it in 10 quarters.
  • Weaver Capital Management's Celularity position peaked at $1.57K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Celularity as of Q3 2026.

Based on Weaver Capital Management's 13F filing for Q3 2026, filed 15 Oct 2026.